However, the Food and Drug Administration (FDA) guidelines do not require the assessment of muscle quality or volume in clinical trials assessing the efficacy of GLP-1 drugs for weight loss
BPC-157 + TB-500 "The Powerful Duo" Serious musculoskeletal injuries muscle tears, tendon ruptures, significant strains where standard recovery timelines just arent cutting it
Diarrhea (loose stools, post-antibiotics, travel) Not everyone on GLP-1 therapy is constipated
W., Niemoeller E., Takami A
However, complete dependence on specific or multiple drugs is associated with short-term or long-term side effects
For peptides that target specific areas, like BPC-157 for tendon injuries , some protocols suggest injecting as close to the affected area as practical